🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

These Analysts Revise Their Forecasts On Intuitive Surgical Following Q1 Results

Published 19/04/2024, 13:10
© Reuters.  These Analysts Revise Their Forecasts On Intuitive Surgical Following Q1 Results
ISRG
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Intuitive Surgical Inc (NASDAQ:ISRG) reported better-than-expected results for its first quarter on Thursday.

Intuitive Surgical reported first-quarter revenue of $1.89 billion, which beat the consensus estimate of $1.87 billion, according to Benzinga Pro. The robotic-assisted surgery company's top-line results were up 11% on a year-over-year basis. Intuitive Surgical reported quarterly adjusted earnings of $1.50 per share, which beat analyst estimates of $1.41 per share.

Intuitive Surgical's da Vinci surgical system installed base totaled 8,887 systems as of March 31, up 14% on a year-over-year basis. The company ended the quarter with $7.32 billion in cash, equivalents and investments.

"The core measures of our business remained healthy this quarter, as we reached meaningful milestones across several parts of our business," said Gary Guthart, CEO of Intuitive Surgical. "We are pleased by feedback from our measured da Vinci 5 launch as well as the continued adoption of SP and Ion, and we remain focused on delivering the goals we share with our customers, including improving patient outcomes."

Intuitive Surgical shares fell 0.4% to close at $372.63 on Thursday.

These analysts made changes to their price targets on Intuitive Surgical following earnings announcement.

  • Baird cut the price target on Intuitive Surgical from $440 to $436. Baird analyst Mike Polark maintained an Outperform rating.
  • Jefferies raised the price target on Intuitive Surgical from $365 to $375. Jefferies analyst David Windley maintained a Hold rating.

Read More: Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Friday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.